Corporate Magazine 2012 - Boehringer Ingelheim

PERSPECTIVES FORQUALITY IN OPERATIONSOperations at Boehringer Ingelheim ensure that patients can relyon receiving high quality medicines.From simple precursors and intermediates handling throughmanufacturing the active pharmaceutical ingredient and producingand delivering the final drug product, it is the responsibility ofoperations to ensure a smooth process.INVESTMENT IN GERMANY[ respimat® production ]SECURE SUPPLY CHAINS[ third-party management ]163m3PM[ eur ]We invest EUR 163m to increase anddouble capacity of the respimat® to44 million packaging units by 2015.The Third Party Management (3PM) networkcurrently includes more than a hundredcontract manufacturing organisations ondifferent continents. It is essential foranalysing and securing Boehringer Ingelheim’ssupply chains.110 Boehringer Ingelheim annual report 2012